Fox News
Breakthrough ALS study launches as drug aims to slow disease progression

The PREVAiLS study, believed to be the only recruiting phase 3 ALS trial, aims to slow disease progression and preserve function in early-stage patients.
F
Source
Fox News
Read full article at Fox News
Opens original article in a new tab
Advertisement



